In this regard, SIRT6 mediates breast cancer cell cancer survival and oxidative stress resistance by regulating intracellular NAMPT activity and NAD(P)(H) levels, suggesting the use of SIRT6 inhibitors and agents inducing oxidative stress as a promising strategy for cancer treatment45. This evidence concerns the gene SIRT6 and breast cancer.